Specific desensitization therapy (TDS) is a method of treating allergic diseases based on the principle of hyposensitization. This method was developed as an alternative to traditional immunotherapy, which is effective but can cause serious side effects.
TDS uses a technique of gradually introducing small doses of the allergen to the patient, starting with very low concentrations and gradually increasing them. This allows the body to gradually get used to the allergen and reduce sensitivity to it. Thus, the patient becomes less susceptible to allergic reactions and symptoms.
Specific hyposensitization (SIT) is an allergy treatment method that uses the same principle of gradually introducing small doses of the allergen. However, unlike TDS, CIT only introduces the patient to one allergen to which they have a reaction. TDS, on the other hand, can be used to treat multiple allergens at the same time.
TDS has been studied in several clinical trials and has shown good results in the treatment of allergic rhinitis, asthma and dermatitis. Most patients treated with TDS report significant improvements in their health and a reduction in the frequency and severity of allergic reactions.
Additionally, TDS is safe and does not cause the serious side effects that may occur with immunotherapy. It can also be used to treat children and pregnant women who cannot undergo immunotherapy.
In conclusion, specific desensitization therapy is an effective and safe treatment for allergic diseases that can help patients reduce their sensitivity to allergens and improve their quality of life. If you have allergies, discuss the possibility of TDS treatment with your doctor.